Kihara James, Principal Accounting Officer at Acadia Pharmaceuticals Inc. ($ACAD), sold shares on the open market six times in the last year, totaling $240,000. His most recent sale occurred on November 18, 2025. These sales rank him 8,049th among 11,678 insiders in our database by total value sold, well below the average of $8.6 million per insider across 6.37 transactions on average. James made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 2142 | $0.00 | 4,284.0000 | 170,650,000 | 33.33% | 0.00% |
| March 26, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 12 | $21.73 | 26,885.0000 | 170,650,000 | 0.04% | 0.00% |
| March 24, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 1627 | $0.00 | 4,883.0000 | 170,650,000 | 24.99% | 0.00% |
| March 26, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 1097 | $21.65 | 26,897.0000 | 170,650,000 | 3.92% | 0.00% |
| March 25, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 2142 | $0.00 | 27,994.0000 | 170,650,000 | 8.29% | 0.00% |
| March 25, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 833 | $21.47 | 25,852.0000 | 170,650,000 | 3.12% | 0.00% |
| March 24, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 1627 | $0.00 | 26,685.0000 | 170,650,000 | 6.49% | 0.00% |
| March 6, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | A | Restricted Stock Units | 6332 | $0.00 | 6,332.0000 | 170,650,000 | 9999.99% | 0.00% |
| March 6, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | A | Stock Option (Right to Buy) | 21766 | $0.00 | 21,766.0000 | 170,650,000 | 9999.99% | 0.01% |
| Nov. 17, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 3966 | $0.00 | 0.0000 | 170,650,000 | 100.00% | 0.00% |
| Nov. 17, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 3966 | $0.00 | 0.0000 | 170,650,000 | 100.00% | 0.00% |
| Nov. 17, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 3966 | $0.00 | 25,176.0000 | 170,650,000 | 18.70% | 0.00% |
| Nov. 17, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 3966 | $0.00 | 29,142.0000 | 170,650,000 | 15.75% | 0.00% |
| Nov. 18, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 4084 | $23.69 | 25,058.0000 | 170,650,000 | 14.01% | 0.00% |
| May 16, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 2000 | $25.00 | 22,395.0000 | 166,362,000 | 8.20% | 0.00% |
| May 16, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 2000 | $20.00 | 20,395.0000 | 166,362,000 | 8.93% | 0.00% |
| May 2, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 1327 | $14.60 | 23,526.0000 | 166,362,000 | 5.34% | 0.00% |
| May 1, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 2596 | $0.00 | 5,192.0000 | 166,362,000 | 33.33% | 0.00% |
| May 1, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 2596 | $0.00 | 24,853.0000 | 166,362,000 | 11.66% | 0.00% |
| April 8, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 1028 | $14.82 | 22,257.0000 | 166,362,000 | 4.41% | 0.00% |
| April 5, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 2010 | $0.00 | 23,285.0000 | 166,362,000 | 9.45% | 0.00% |
| April 5, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 2010 | $0.00 | 2,010.0000 | 166,362,000 | 50.00% | 0.00% |
| March 24, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | A | Stock Option (Right to Buy) | 22152 | $0.00 | 22,152.0000 | 166,362,000 | 9999.99% | 0.01% |
| March 25, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 2142 | $0.00 | 6,426.0000 | 166,362,000 | 25.00% | 0.00% |
| March 24, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | A | Restricted Stock Units | 6510 | $0.00 | 6,510.0000 | 166,362,000 | 9999.99% | 0.00% |
| March 25, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 2142 | $0.00 | 22,370.0000 | 166,362,000 | 10.59% | 0.00% |
| March 26, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 1095 | $17.05 | 21,275.0000 | 166,362,000 | 4.89% | 0.00% |
| Feb. 23, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 840 | $0.00 | 20,703.0000 | 166,362,000 | 4.23% | 0.00% |
| Feb. 23, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 840 | $0.00 | 0.0000 | 166,362,000 | 100.00% | 0.00% |
| Feb. 24, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 475 | $19.96 | 20,228.0000 | 166,362,000 | 2.29% | 0.00% |
| Nov. 17, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 3965 | $0.00 | 23,936.0000 | 166,178,000 | 19.85% | 0.00% |
| Nov. 17, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 3965 | $0.00 | 19,971.0000 | 166,178,000 | 24.77% | 0.00% |
| Nov. 17, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 3965 | $0.00 | 3,966.0000 | 166,178,000 | 49.99% | 0.00% |
| Nov. 17, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 3965 | $0.00 | 3,966.0000 | 166,178,000 | 49.99% | 0.00% |
| Nov. 19, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 4073 | $16.81 | 19,863.0000 | 166,178,000 | 17.02% | 0.00% |
| May 1, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 2596 | $0.00 | 7,788.0000 | 163,819,000 | 25.00% | 0.00% |
| May 1, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 2596 | $0.00 | 15,696.0000 | 163,819,000 | 19.82% | 0.00% |
| May 2, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 1326 | $16.94 | 14,370.0000 | 163,819,000 | 8.45% | 0.00% |
| April 8, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 762 | $17.87 | 13,100.0000 | 163,819,000 | 5.50% | 0.00% |
| April 5, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 2010 | $0.00 | 13,401.0000 | 163,819,000 | 17.65% | 0.00% |
| April 7, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 1489 | $0.00 | 14,890.0000 | 163,819,000 | 11.11% | 0.00% |
| April 8, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 1028 | $17.87 | 13,862.0000 | 163,819,000 | 6.90% | 0.00% |
| April 5, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 2010 | $0.00 | 4,020.0000 | 163,819,000 | 33.33% | 0.00% |
| April 7, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 1489 | $0.00 | 0.0000 | 163,819,000 | 100.00% | 0.00% |
| March 25, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | A | Stock Options (Right to Buy) | 13964 | $0.00 | 13,964.0000 | 163,819,000 | 9999.99% | 0.01% |
| March 25, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | A | Restricted Stock Units | 8568 | $0.00 | 8,568.0000 | 163,819,000 | 9999.99% | 0.01% |
| Feb. 23, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Restricted Stock Units | 840 | $0.00 | 840.0000 | 163,819,000 | 50.00% | 0.00% |
| Feb. 23, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | M | Common Stock | 840 | $0.00 | 11,865.0000 | 163,819,000 | 7.62% | 0.00% |
| Feb. 26, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | PRINCIPAL ACCOUNTING OFFICER | S | Common Stock | 474 | $24.67 | 11,391.0000 | 163,819,000 | 3.99% | 0.00% |
| Dec. 15, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | S | Common Stock | 2000 | $28.30 | 11,025.0000 | 161,683,000 | 15.36% | 0.00% |
| Nov. 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Restricted Stock Units | 1982 | $0.00 | 7,931.0000 | 161,683,000 | 19.99% | 0.00% |
| Nov. 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Restricted Stock Units | 1982 | $0.00 | 7,931.0000 | 161,683,000 | 19.99% | 0.00% |
| Nov. 20, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | S | Common Stock | 1985 | $22.64 | 13,025.0000 | 161,683,000 | 13.22% | 0.00% |
| Nov. 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Common Stock | 1982 | $0.00 | 15,010.0000 | 161,683,000 | 15.21% | 0.00% |
| Nov. 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Common Stock | 1982 | $0.00 | 13,028.0000 | 161,683,000 | 17.94% | 0.00% |
| Sept. 15, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | S | Common Stock | 2000 | $25.88 | 10,778.0000 | 161,683,000 | 15.65% | 0.00% |
| June 15, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | S | Common Stock | 2000 | $24.15 | 9,144.0000 | 161,683,000 | 17.95% | 0.00% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Common Stock | 5947 | $0.00 | 17,091.0000 | 161,683,000 | 53.37% | 0.00% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Common Stock | 5947 | $0.00 | 11,144.0000 | 161,683,000 | 114.43% | 0.00% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Restricted Stock Units | 5947 | $0.00 | 9,913.0000 | 161,683,000 | 37.50% | 0.00% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | S | Common Stock | 5947 | $22.50 | 11,144.0000 | 161,683,000 | 34.80% | 0.00% |
| May 17, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Restricted Stock Units | 5947 | $0.00 | 9,913.0000 | 161,683,000 | 37.50% | 0.00% |
| May 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | A | Restricted Stock Units | 10384 | $0.00 | 10,384.0000 | 161,683,000 | 9999.99% | 0.01% |
| May 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | A | Stock Options (Right to Buy) | 17131 | $0.00 | 17,131.0000 | 161,683,000 | 9999.99% | 0.01% |
| April 10, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | S | Common Stock | 523 | $18.14 | 5,197.0000 | 161,683,000 | 9.14% | 0.00% |
| April 7, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Common Stock | 1489 | $0.00 | 5,720.0000 | 161,683,000 | 35.19% | 0.00% |
| April 7, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Restricted Stock Units | 1489 | $0.00 | 1,489.0000 | 161,683,000 | 50.00% | 0.00% |
| April 5, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Restricted Stock Units | 2009 | $0.00 | 6,030.0000 | 161,683,000 | 24.99% | 0.00% |
| April 6, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | S | Common Stock | 701 | $18.16 | 4,231.0000 | 161,683,000 | 14.21% | 0.00% |
| April 5, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Common Stock | 2009 | $0.00 | 4,932.0000 | 161,683,000 | 68.73% | 0.00% |
| Feb. 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Restricted Stock Units | 840 | $0.00 | 1,680.0000 | 161,683,000 | 33.33% | 0.00% |
| Feb. 23, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | M | Common Stock | 840 | $0.00 | 3,273.0000 | 161,683,000 | 34.53% | 0.00% |
| Feb. 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Kihara James | Principal Accounting Officer | S | Common Stock | 350 | $18.78 | 2,923.0000 | 161,683,000 | 10.69% | 0.00% |